_________________________________________________________________________________ ASX Release Conversion of Performance Rights & Cleansing Notice ADELAIDE, 24 August 2026: Anatara Lifesciences Ltd (ASX: ANR or “the Company”) advises that it has today converted 359,640...
Conversion of Performance Rights and Cleansing Notice
Filed with ASX · · 2 pages · English
Release
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Appendix 4E & Financial Report 30 June 2026
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4D & Half Year Report 31 December 2025
- Company Update
- Anatara receives firm commitments for $1.2m Placement
Later from Anatara Lifesciences
- Application for quotation of securities - ANR
- Change of Director's Interest Notice
- Anatara receives $318,402 in R&D Tax Incentive for FY26
- Date of 2026 Annual General Meeting
- Annual Report to shareholders
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences